BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6645082)

  • 21. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
    J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of Hodgkin's disease and cutaneous B-cell lymphoma in the same patient: a report of two cases.
    Servitje O; Martí RM; Estrach T; Palou J; Gallardo F; Limón A; Romagosa V
    Eur J Dermatol; 2000; 10(1):43-6. PubMed ID: 10694298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
    Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
    J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
    Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
    Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.
    Paltiel O; Schmit T; Adler B; Rachmilevitz EA; Polliack A; Cohen A; Haim N; Shachar MB; Epelbaum R; Barchana M; Cohen R; Ben Yehuda D
    Cancer; 2000 May; 88(10):2357-66. PubMed ID: 10820359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia.
    Polychronopoulou S; Panagiotou JP; Papadakis T; Mavrou A; Anagnostou D; Haidas S
    Med Pediatr Oncol; 1996 May; 26(5):359-66. PubMed ID: 8614370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose intensified molecular targeted radiotherapy for cancer-lymphoma as a paradigm.
    DeNardo G; DeNardo S
    Semin Nucl Med; 2010 Mar; 40(2):136-44. PubMed ID: 20113681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anaplastic epithelioma of the thyroid gland 6 years after cervical irradiation for malignant lymphoma].
    Voisin M; Tawil E; LeBuis FF; Bettez P; Somma M
    Can Med Assoc J; 1975 Oct; 113(7):648-52. PubMed ID: 1181021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group.
    Tucker MA; Jones PH; Boice JD; Robison LL; Stone BJ; Stovall M; Jenkin RD; Lubin JH; Baum ES; Siegel SE
    Cancer Res; 1991 Jun; 51(11):2885-8. PubMed ID: 1851664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Late complications of radiation therapy in patients with malignant lymphoma].
    Masaki N
    Gan No Rinsho; 1988 Apr; 34(5):715-24. PubMed ID: 3290534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thyroid dysfunction following external irradiation of the neck].
    Hayabuchi N; Jingu K; Masuda K; Masaki N; Morita K; Kaneta K
    Gan No Rinsho; 1987 Aug; 33(10):1146-50. PubMed ID: 3669307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary thyroid lymphoma: clinical features, treatment and outcome: a report of 8 cases.
    Brownlie BE; Fitzharris BM; Abdelaal AS; Hay NM; Bremner JM; Hamer JW
    N Z Med J; 1994 Aug; 107(983):301-4. PubMed ID: 8052462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid carcinoma and hyperparathyroidism after radiation therapy for adolescent acne vulgaris.
    De Jong SA; Demeter JG; Jarosz H; Lawrence AM; Paloyan E
    Surgery; 1991 Oct; 110(4):691-5. PubMed ID: 1833847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thyroid nodules and cancer in patients with Hodgkin's lymphoma after radiotherapy].
    Khalil' EF; Sotnikov VM; Pan'shin GA; Parkhomenko RA; Shcherbenko OI; Sycheva NA
    Vestn Rentgenol Radiol; 2008; (2-3):10-5. PubMed ID: 21337757
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thyroid cancer induced by radiotherapy. Clinico-anatomopathological comparison with spontaneously occurring cancer].
    Turrin A; Basso-Ricci S
    Radiol Med; 1987 Dec; 74(6):559-62. PubMed ID: 3432614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of malignant lymphoproliferative disorders of the nervous system.
    Williams CK
    Afr J Med Med Sci; 1984; 13(3-4):93-101. PubMed ID: 6099982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.